Inhibition of the phosphorylation of vascular endothelial growth factor receptor 2 (VEGFR2), Src, and FAK through Sema3A led to substantial reductions in tumor growth and angiogenesis in tongue SSC-9 cells, illustrating the potential of this approach for cancer therapy [63]. Here, PTK2 is linked to cancer.